Physician profile
Aaron W Maddox
NPI 1235143777
$9,014.29
in general payments reported to CMS, 2019-2025
49 companies · $2,276 in 2025
The $2,276 reported for 2025 was more than what 94% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $267 · 2020: $16.83 · 2021: $1,106 · 2022: $1,999 · 2023: $1,536 · 2024: $1,814 · 2025: $2,276.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,509 · Education: $117.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,508.69 |
| Education | $116.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,706.26 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Astrazeneca Pharmaceuticals LP | $1,236.09 | 2021-2025 | Airsupra, Farxiga, Breztri |
| Lilly USA, LLC | $560.19 | 2021-2025 | Mounjaro, Zepbound, Jardiance |
| Glaxosmithkline, LLC. | $554.45 | 2019-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Bayer Healthcare Pharmaceuticals INC. | $459.86 | 2022-2025 | |
| Teva Pharmaceuticals USA, INC. | $434.39 | 2021-2025 | Uzedy, Ajovy, Austedo Xr |
| Abbvie INC. | $388.62 | 2021-2025 | |
| Dexcom, INC. | $313.53 | 2021-2025 | Dexcom G7 Gss (161), Dexcom Stelo Glucose Biosensor, Dexcom G6 Transmitter |
| Regeneron Healthcare Solutions, INC. | $308.70 | 2024-2025 | Dupixent |
| Abbott Laboratories | $272.54 | 2021-2024 | Freestyle Libre 2, Freestyle Libre 3 |
| Sumitomo Pharma America, INC. | $231.15 | 2023-2025 | Gemtesa |
| Exact Sciences Corporation | $179.64 | 2023-2025 | Cologuard Collection Kit |
| Boston Scientific Corporation | $179.63 | 2022 | |
| Inari Medical, INC. | $167.50 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Pfizer INC. | $149.05 | 2020-2023 |
Show all 49 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aaron Maddox listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.